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In contrast to the accepted pro-proliferative effect
of cell-matrix adhesion, the proliferative effect of
cadherin-mediated cell-cell adhesion remains unre-
solved. Here, we studied the effect of N-cadherin
on cell proliferation in the vasculature. We show
that N-cadherin is induced in smooth muscle cells
(SMCs) in response to vascular injury, an in vivo
model of tissue stiffening and proliferation. Com-
plementary experiments performed with de-
formable substrata demonstrated that stiffness-
mediated activation of a focal adhesion kinase
(FAK)-p130Cas-Rac signaling pathway induces
N-cadherin. Additionally, by culturing paired and
unpaired SMCs on microfabricated adhesive
islands of different areas, we found that N-cad-
herin relaxes the spreading requirement for SMC
proliferation. In vivo SMC deletion of N-cadherin
strongly reduced injury-induced cycling. Finally,
SMC-specific deletion of FAK inhibited proliferation
after vascular injury, and this was accompanied by
reduced induction of N-cadherin. Thus, a stiffness-
and FAK-dependent induction of N-cadherin con-
nects cell-matrix to cell-cell adhesion and regu-
lates the degree of cell spreading needed for
cycling.INTRODUCTION
The stimulation and arrest of cell proliferation are tightly regu-
lated throughout embryonic and adult life. Such regulation is
achieved primarily through the interaction of cells with their
surrounding soluble and adhesive environment. Growth factor
receptors trigger numerous mitogenic signaling pathwaysCellthat are complemented by integrin-mediated adhesion to
extracellular matrix (ECM), which provides necessary co-stim-
ulatory signals for proliferation (Assoian and Klein, 2008;
Chrzanowska-Wodnicka and Burridge, 1996; Geiger et al.,
2001; Parsons et al., 2010; Schwartz, 2010). Additionally, early
studies with drugs that disrupt actin polymerization or with mi-
cropatterned adhesive islands of distinct sizes revealed that
the adhesion requirement for proliferation is directly related
to the organization of the actin cytoskeleton and the degree
of actin-mediated cell spreading (Assoian and Klein, 2008;
Chen et al., 1997).
Compared with the mitogenic effects of growth factors and
ECM, the effects of cadherins on proliferation have been more
controversial. Several studies have linked cadherin engagement
to inhibition of proliferation in vitro and in vivo (Baumeister et al.,
2005; Chalasani and Brewster, 2011; Grazia Lampugnani et al.,
2003; Hay¨ et al., 2009; Kim et al., 2011; Sakane and Miyamoto,
2013; Stockinger et al., 2001; Uglow et al., 2003). However,
cell-cell contact through cadherins also promotes cell cycling
in vitro and in vivo (Fournier et al., 2008; Nelson and Chen,
2002; Reddy et al., 2005; Tinkle et al., 2004; Zhu and Watt,
1996). This diversity of stimulatory and inhibitory responses
strongly suggests that the cellular context affects cadherin-
mediated proliferation.
Here, we used complementary in vivo and in vitro approaches
to examine the effect of cadherin engagement on the prolifera-
tion of vascular smooth muscle cells (SMCs). The proliferation
of these cells plays critical roles in cardiovascular disease (Jones
et al., 2002; Owens et al., 2004; Sabatini et al., 2008), and cell-
cell adhesion in SMCs is largely mediated by a single cadherin
(N-cadherin) (Resink et al., 2009). We show that N-cadherin is
induced by ECM stiffness and focal adhesion kinase (FAK),
and this induction is essential for FAK-mediated SMC cycling
in vivo. Thus, our work reveals a new role for N-cadherin in
cell-cycle control within the vasculature, a new mechanism of
stiffness-dependent crosstalk between cell-substratum and
cell-cell adhesion, and a basis for the stimulatory effect of cad-
herin on proliferation.Reports 10, 1477–1486, March 10, 2015 ª2015 The Authors 1477
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Figure 1. N-Cadherin Is Essential for In Vivo
SMC Proliferation
(A) Uninjured and injured femoral artery sections
from wild-type mice (n = 9) were im-
munohistochemically stained for N-cadherin. The
media (M) lies between the dashed white lines,
which mark the internal and external elastic
laminae. The neointima (NI) seen in injured arteries
is the region between internal elastic lamina and
lumen. Images on the right are magnifications of
the inset black boxes in the left-hand images.
(B) N-cadherin expression in the injured and un-
injured femoral arteries of each mouse was scored
by blinded grouping (inj, injured; uninj, uninjured).
(C) In vivo SMC proliferation was examined by
in vivo BrdU labeling in injured femoral arteries
from vehicle-treated (n = 8) and tamoxifen-treated
(n = 7) N-cadherinfl/fl;iCre mice.
(D) Results in (C) were quantified by manual
counting and plotted as mean + SD.
(E) Asynchronous SMCs were cultured on FN-
coated PA hydrogels (2, 11, and 24 kPa) for 24 hr in
10% FBS and analyzed by western blot. The bar
graph shows N-cadherin levels normalized to
control and plots results as mean + SE; n = 3.
See also Figure S1.RESULTS
N-Cadherin Is Essential for Tamoxifen Proliferation
In Vivo
We tested the physiological importance ofN-cadherin expression
in the in vivo response to vascular injury in the mouse. Because
global deletion of N-cadherin leads to lethal cardiovascular de-
fects during embryogenesis (Radice et al., 1997), we conditionally
deleted N-cadherin in SMCs of adult mice. In healthy arteries,
SMCs are in a differentiated, contractile state and exhibit a low
rate of proliferation (Owens et al., 2004). Vascular injury damages
theendothelial cell layer,which leads toaggregationof platelets at
the sites of the injury, secretion of growth factors, and dedifferen-
tiation,migration, andproliferationof theunderlyingmedial SMCs.
These events culminate in the formation of a neointima that is pre-
dominantly composed of vascular SMCs (Sata et al., 2000).1478 Cell Reports 10, 1477–1486, March 10, 2015 ª2015 The AuthorsConsistent with work of Jones et al.
(2002), immunohistochemical analysis
of femoral artery sections from wild-
type mice showed that N-cadherin was
barely detectable in uninjured arteries,
but was strongly induced in the media
and neointima following injury (Fig-
ure 1A), with 80% of the mice having
higher N-cadherin levels in injured ar-
teries than in contralateral uninjured ar-
teries (Figure 1B). We were able to link
this increase in N-cadherin expression
to in vivo cell proliferation because
when we injured femoral arteries in
N-cadherinfl/fl;iCre mice expressing a
tamoxifen-inducible SMC-specific Cre,we found that induction of N-cadherin (Figure S1A), neointimal
formation (Figure S1B), and cell proliferation (Figures 1C and
1D) were all reduced. Controls showed that proliferating cells
were not detected in uninjured femoral arteries (Figure S1C),
apoptosis was not affected by the deletion of SMC N-cadherin
(Figure S1D), and tamoxifen did not affect the number of
S-phase nuclei after vascular injury in mice lacking Cre
(Figure S1E).
N-Cadherin Gene Expression Is Regulated by the
Stiffness-Sensitive FAK-Cas-Rac Pathway
Vascular injury is associated with an increase in arterial stiffness
from 2–4 kPa to 10–24 kPa (Klein et al., 2009). To study the effect
of ECM stiffness on the levels of N-cadherin, we cultured
SMCs and mouse embryonic fibroblasts (MEFs) on fibronectin
(FN)-coated polyacrylamide (PA) hydrogels spanning this
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Figure 2. N-Cadherin Is Regulated by Rac
(A) Serum-starvedMEFs were suspended in 10% FBS, seeded on stiff FN-coated hydrogels (24 kPa), and treated with 10 mMof the Rho kinase inhibitor Y-27632
or 150 mMof the Rac inhibitor NSC23766 for 20 hr. The elastic moduli of individual cells were determined by atomic forcemicroscopy; n = 3. Results are plotted as
mean + SD.
(B and C) Serum-starved MEFs treated with (B) 10 mMY-27632 or (C) 150 mMNSC23766 on stiff FN-coated PA hydrogels (24 kPa) for 20–24 hr in 10% FBS were
analyzed by western blot; n = 3–4.
(D) Serum-starved MEFs transfected with 200 nM non-specific (NS) or Rac1 siRNA, or infected with dominant-negative RacN17 adenovirus were cultured on stiff
FN-coated PA hydrogels in 10% FBS for 9 hr. Cells were lysed and analyzed by western blot; n = 3.
(E) Serum-starvedMEFswere infected with adenoviral vectors expressing LacZ or RacV12, and cultured on soft FN-coated PA hydrogels (2 kPa) with 10%FBS for
9 hr and analyzed by western blot; n = 4.
(F) MEFs in 10% FBS were infected with adenovirus expressing GFP, RacN17, b2-chimaerin (b2-ch), FRNK, or FAKY397F (Y397F) for 24 hr, lysed, and examined by
western blot; n = 3.
The bar graphs under (B)-(F) show N-cadherin normalized to control and are plotted as mean + SE.
See also Figure S2.pathophysiologic range of stiffness, and stimulated them with
fetal bovine serum (FBS). N-cadherin expression was directly
proportional to ECM stiffness in both SMCs (Figure 1E) and
MEFs (Figure S1F). ECM stiffening has several effects on cells,
including an increase in actin-dependent intracellular stiffness
(Bae et al., 2014; Paszek et al., 2005; Solon et al., 2007), and
intracellular stiffness is regulated by both Rho-GTP and Rac-
GTP (Figure 2A). We inhibited Rho- and Rac-dependent stiff-
ening, respectively, with the Rho kinase inhibitor Y-27632 (Fig-
ure 2B) or the Rac inhibitor NSC23766 (Figure 2C) to determine
which small GTPase played the major role in stiffness-depen-
dent induction of N-cadherin. MEFs treated with these inhibitorsCellwere cultured on stiff hydrogels (24 kPa). Inhibition of Rho kinase
did not affect N-cadherin expression (Figure 2B) as compared
with the reduced N-cadherin levels seen upon inhibition of
Rac-GTP (Figure 2C). Expression of Rac1 small interfering
RNA (siRNA) or dominant-negative Rac (RacN17) in MEFs also
reduced the expression of N-cadherin protein on stiff hydrogels
(Figure 2D). Conversely, expression of a constitutively active Rac
(RacV12) allowed for N-cadherin expression in cells cultured on a
soft hydrogels (2 kPa) (Figure 2E). A similar reduction in N-cad-
herin expression was seen in MEFs (Figure 2F) and SMCs (Fig-
ure S2A) when Rac activity was inhibited by ectopic expression
of RacN17 or b2-chimaerin (a Rac GAP) on a rigid substratum.Reports 10, 1477–1486, March 10, 2015 ª2015 The Authors 1479
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Figure 3. N-Cadherin Is Induced by FAK-Src-Cas Signaling
(A)MEFswere transfectedwith 200 nMof two distinct FAK siRNAs or a nonspecific (NS) siRNA. The cells were then serum starved for 48 hr, incubated in 10%FBS
for 20 hr, and analyzed by western blot; n = 3.
(B) Serum-starved MEFs were treated with different concentrations of the small-molecule FAK inhibitor PF573228 for 20 hr in 10% FBS and analyzed by western
blot; n = 4.
(C) N-cadherinfl/fl MEFs in 10% FBS were infected overnight with 1,000 moi of adenovirus expressing GFP or Cre and analyzed by western blot; n = 3.
(D) Serum-starved MEFs were either transfected with 200 nM of two distinct siRNAs against p130Cas or paxillin, or a non-specific (NS) siRNA, or infected with
1,000 moi adenoviral FRNK. Cells were then incubated with 10% FBS for 24 hr, lysed, and examined by western blot; n = 3.
(E) Serum-starved SYF null MEFs cultured on stiff FN-coated PA hydrogels (24 kPa) were incubated with 10% FBS for 9 hr, lysed, and examined by western blot;
n = 3. The bar graphs under (A)–(E) show N-cadherin levels normalized to control and are plotted as mean + SE.
(F) MEFs in 10% FBS were treated with 20 mM PF573228 for 20 hr or infected with FAKY397F (Y397F) adenovirus for 24 hr. The relative expression of N-cadherin
mRNA was examined by quantitative RT-PCR. Results are shown as mean + SE; n = 3.
See also Figure S3.FAK and p130Cas are upstream of stiffness-sensitive Rac ac-
tivity (Bae et al., 2014). We inhibited FAK activity by ectopic
expression of dominant-negative constructs (FRNK or FAKY397F)
or depleted FAK with siRNA, and found that these two treat-
ments reduced N-cadherin levels in both cell types on a rigid1480 Cell Reports 10, 1477–1486, March 10, 2015 ª2015 The Authorsubstratum (Figures 2F, S2B, 3A, and S3A), as did depletion of
FAK in cells on stiff hydrogels (Figure S3B). Furthermore,
exposing MEFs to the pharmacologic FAK inhibitor PF573228
also reduced N-cadherin expression (Figure 3B), and the effect
was proportional to the inhibition of FAK activity as judged bys
phosphorylation at Y397 (Figure 3B). In contrast, Cre-mediated
excision of the floxed N-cadherin allele in N-cadherinfl/fl MEFs
yielded no changes in either FAK autophosphorylation or the
overall levels of FAK (Figure 3C). Thus, a unidirectional crosstalk
from FAK to N-cadherin connects cell-substratum adhesion to
cell-cell adhesion.
FAK activity leads to the phosphorylation of paxillin (Turner,
2000) and p130Cas (Cary et al., 1998; Fonseca et al., 2004).
Knockdown of p130Cas, but not paxillin, with siRNA
decreased N-cadherin levels in MEFs cultured on a rigid sub-
stratum (Figure 3D), and the p130Cas effect on N-cadherin
was confirmed in SMCs (Figure S3C). Moreover, we were
able to link this effect of p130Cas to FAK because inhibition
of FAK with FRNK reduced the levels of both activated
p130CaspY410 and N-cadherin (Figure 3D, FRNK). Src has
been implicated in the phosphorylation of FAK and Cas (Ruest
et al., 2001; Schlaepfer and Hunter, 1996). Even though Src
expression and activity are not strongly sensitive to stiffness
(Bae et al., 2014), FAK phosphorylation on Src sites (Y576
and Y861) and N-cadherin expression were low in SYF null
cells (which are deficient in the Src family kinase proteins
Src, Yes, and Fyn) when cultured on stiff hydrogels and
restored by reconstitution of the cells with c-Src (Figure 3E).
Because Src is recruited to FAK autophosphorylated at Y397
(Mitra and Schlaepfer, 2006; Schaller et al., 1994), our interpre-
tation of these results is that the stiffness sensitivity of FAK au-
tophosphorylation renders Src-dependent FAK phosphoryla-
tion sensitive to stiffness despite the constitutively expressed
Src. Collectively, these results indicate that the stiffness-sensi-
tive FAK/Src-Cas-Rac signaling pathway regulates stiffness-
dependent N-cadherin gene expression.
We used Ingenuity Pathway Analysis to identify other possible
signaling pathways downstream of p130Cas (here called by its
gene name, BCAR1) and upstream of N-cadherin (CDH2) gene
expression. In addition to Rac, this global approach identified
transforming growth factor (TGF)-b/Smad signaling and c-Jun
N-terminal kinase (JNK) as potential upstream regulators of
N-cadherin (Figure S3D). However, N-cadherin gene expression
was minimally affected by treatment with TGF-b (Figure S3E) or
by JNK inhibition with SP600125 (Figure S3F). Thus, stiffness-
dependent activation of the FAK-Cas-Rac pathway plays the
major role in inducing N-cadherin in response to increased sub-
stratum stiffness.
FAK and Rac inhibition reduced the levels of N-cadherin
mRNA (Figures 3F and S3G). Twist is mechanically regulated
(Desprat et al., 2008) and is one of the transcription factors
that stimulates N-cadherin gene transcription (Oda et al., 1998;
Yang et al., 2004). Inhibition of FAK or Rac suppressed the
expression of Twist1 mRNA (Figure S3H). Moreover, siRNA-
mediated knockdown of Twist1 mRNA decreased N-cadherin
mRNA levels in MEFs (Figure S3I) and SMCs (Figure S3J).
Thus, a FAK-Rac-Twist pathway likely contributes to the regula-
tion of N-cadherin.
N-Cadherin Attenuates the Spreading Requirement
for Proliferation
Our data suggest that ECM stiffening at sites of vascular injury
leads to the induction of N-cadherin, and the inducedN-cadherinCellstimulates SMC proliferation in vivo. We tried to model this effect
in vitro by performing proliferation assays in N-cadherinfl/fl MEFs
or SMCs cultured on plastic or hydrogels and infected with
adenoviral vectors expressing GFP (Ad-GFP) or Cre recombi-
nase (Ad-Cre). However, the random distribution and migration
of cells led to inconsistent cell-cell contacts and N-cadherin
signaling. Therefore, we fabricated unpaired and paired micro-
patterned islands on a glass substrate, which allowed us to sys-
tematically control cell-cell contact (Figure S4A) while preserving
the stiff surface that is permissive for FAK activation and N-cad-
herin expression. We then compared S-phase entry of primary
N-cadherinfl/fl SMCs that were infected with Ad-GFP or Ad-Cre
and seeded on FN-coated micropatterned islands with an area
of 4,900 mm2 per cell. In cells expressing Ad-GFP, physical con-
tact between paired cells increased S-phase entry as compared
with unpaired cells (Figure 4A). This effect was greatly reduced in
cells infected with Ad-Cre (Figure 4A), demonstrating that the
stimulatory effect of cell-cell adhesion in this system is largely
mediated by N-cadherin.
ECM stiffening leads to cell spreading (Pelham and Wang,
1997), and cell spreading on ECM drives proliferation (Chen
et al., 1997). Although one can manipulate cell spreading by
culturing cells on ECM-coated hydrogels of varying stiffness,
the stiffness-dependent induction of N-cadherin precluded us
from using hydrogels to study the effect of endogenous N-cad-
herin on cell cycling. Therefore, we asked how the engagement
of N-cadherin affected this spreading requirement for prolifera-
tion using unpaired and paired adhesive islands of distinct areas
(both smaller [2,500 mm2] and larger [10,000 mm2] than those
used in Figure 4A). FAK activation and N-cadherin-containing
adherens junctions were readily detected in micropatterned
islands of both sizes (Figure S4B). Curiously, FAK activity (as
judged by the intensity of FAKpY397) was somewhat greater in
SMCs on smaller micropatterned islands. The N-cadherin signal
at adherens junctions was also much stronger in the smaller mi-
cropatterned islands.
Serum-starved SMCs in small and large micropatterns were
incubated with 10% FBS, and S-phase entry was monitored
by 5-ethynyl-20-deoxyuridine (EdU) incorporation (Figure 4B).
S-phase entry was directly related to the degree of cell spreading
in unpaired cells (Figure 4C), and FAKwas required for this effect
(Figure S4C), consistent with earlier work (Bae et al., 2014; Chen
et al., 1997; Klein et al., 2009). However, when cells were
cultured in the paired islands, where N-cadherin-mediated cell-
cell adhesion is functionally significant (refer to Figure 4A), cell
cycling became much less dependent on cell spreading (Fig-
ure 4C). Thus, this micropatterning system successfully modeled
the pro-proliferative effect of N-cadherin on SMCs that we
observed after vascular injury (Figures 1C and 1D). Moreover,
the results suggest that the increased presence of N-cadherin
after vascular injury may contribute to SMC proliferation by re-
laxing the spreading requirement for cycling of SMCs within
the arterial wall.
Consistent with the reduced expression of N-cadherin (refer
to Figure 3), inhibition of endogenous FAK activity with FRNK
or FAKY397F reduced the number of S-phase cells in the small,
paired micropatterned islands where the stimulatory effect of
N-cadherin on cell cycling is most evident (Figure 4D). Similarly,Reports 10, 1477–1486, March 10, 2015 ª2015 The Authors 1481
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Figure 4. N-Cadherin Determines the Spreading Requirement for Proliferation
(A) Serum-starved N-cadherinfl/fl SMCs infected with adenoviral GFP or Cre were cultured on unpaired or paired micropatterned adhesive islands (4,900 mm2),
stimulated with 10% FBS for 48 hr, and analyzed for S-phase entry by EdU incorporation.
(B) Representative images of EdU-positive SMCs on 10,000 mm2 unpaired or pairedmicropatterned adhesive islands. Cells were immunofluorescently co-stained
for DAPI and EdU.
(C) SMCs were cultured on different-sized micropatterned adhesive islands (2,500 and 10,000 mm2) with 10% FBS for 48 hr and analyzed for S-phase entry by
EdU incorporation.
(D) Serum-starved SMCs were infected with adenoviral GFP, FRNK or FAKY397F (Y397F) without or with adenoviral N-cadherin, seeded on micropatterned
adhesive islands (2,500 mm2) with 10% FBS for 48 hr, and analyzed for S-phase entry. All S-phase results are plotted as mean + SE; n = 3.
See also Figure S4.siRNA-mediated knockdown of FAK also reduced S-phase entry
in cells on these small, paired micropatterned islands, although
the effect was somewhat less pronounced than that seen with
FRNK or FAKY397F (Figure S4D). FRNK or FAKY397F also inhibited
S-phase entry on the small islands when N-cadherin was ectop-
ically expressed (Figure 4D). Our interpretation of these results is
that N-cadherin is necessary, but not sufficient, for FAK-medi-
ated proliferation when cell spreading is constrained.
N-Cadherin Is an Essential Effector of FAK-Mediated
Cell Cycling In Vivo
Since N-cadherin induction is FAK dependent, deletion of FAK
should also inhibit in vivo SMC proliferation. Initial experiments
showed that FAK phosphorylation at Y397 was increased after
vascular injury in wild-type mice (Figures S5A and S5B). We
then determined the effect of SMC-specific FAK deletion during
the response to vascular injury by treating FAKfl/fl;iCre mice with
vehicle or tamoxifen (Figure S5C). S-phase nuclei were not de-
tected in uninjured vehicle- or tamoxifen-treated FAKfl/fl;iCre1482 Cell Reports 10, 1477–1486, March 10, 2015 ª2015 The Authormice (Figure S5D). However, SMC-specific deletion of FAK
with tamoxifen strongly reduced the proliferative response to
injury (Figures 5A and 5B) and neointimal formation (Figure S5E).
The reduction in S-phase nuclei was similar to that seen after
SMC-specific deletion of N-cadherin (refer to Figures 1C and
1D). Moreover, N-cadherin upregulation after injury was
apparent in vehicle-treated FAKfl/fl;iCre mice (Figure 5C), but
was blunted when the mice were given tamoxifen (Figure 5D).
Blinded quantification of these data indicated that the N-cad-
herin signal intensity after injury greatly exceeded that in the un-
injured contralateral controls in 60% of vehicle-treated mice, but
in only 12.5% of tamoxifen-treated mice (Figure 5E). In striking
contrast, deletion of N-cadherin reduced SMC proliferation after
injury without inhibiting the phosphorylation of FAK (Figures 5F,
S5F, and 5G) or p130Cas (Figures 5H, S5G, and 5I). This in vivo
epistatic relationship is remarkably consistent with our in vitro
epistasis data, and indicates that unidirectional crosstalk from
FAK to N-cadherin is essential for FAK-dependent proliferation
during the in vivo proliferative response to vascular injury.s
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Figure 5. N-Cadherin Is an Essential Effector of FAK-Regulated SMC Cycling In Vivo
(A) Injured femoral arteries from vehicle-treated (n = 7) and tamoxifen-treated (n = 8) FAKfl/fl;iCre mice were stained for incorporated BrdU. Images on the right are
magnifications of the inset black boxes in the left-hand images.
(B) The number of S-phase nuclei in the neointima (NI) and media (M) of vehicle-treated (n = 7) and tamoxifen-treated (n = 8) mice was determined by manual
counting and plotted as mean + SD.
(C and D) Femoral artery sections from (C) vehicle- and (D) tamoxifen-treated FAKfl/fl;iCre mice were stained for N-cadherin.
(E) Blinded grouping of the vehicle (n = 5) and tamoxifen (n = 8) data in (C) and (D). Statistical significance was determined by chi-square test; p < 000.1.
(legend continued on next page)
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DISCUSSION
Our work establishes the proliferative effect of N-cadherin in
vascular SMCs, reveals the regulation of N-cadherin by a FAK-
p130Cas-Rac pathway, and indicates that this crosstalk be-
tween cell-substratum and cell-cell adhesion is essential for
FAK-dependent SMC proliferation in vivo. Our in vitro experi-
ments show that a unidirectional crosstalk from FAK to N-cad-
herin regulates cell cycling in a spreading-dependent manner.
In line with recent evidence demonstrating that cadherins are
mechanosensors (Chopra et al., 2011; Conway et al., 2013; le
Duc et al., 2010; Tzima et al., 2005), we show that N-cadherin
expression changes with substrate stiffness. This crosstalk be-
tween ECM stiffness and N-cadherin may also occur in vivo as
increased N-cadherin levels are linked to increased tissue stiff-
ness during the response to vascular injury.
The small GTPases Rho and Rac are well-known regulators of
cadherin adhesiveness and signaling. Coordinated signaling
among different Rho family GTPases regulates cell-cell adhe-
sions across different cell types (Braga et al., 2000; Takaishi
et al., 1997; Watanabe et al., 2009; Wildenberg et al., 2006). In
mesenchymal stem cells, N-cadherin-mediated cell-cell adhe-
sion and expression are modulated by Rac signaling (Gao
et al., 2010; Woods et al., 2007). We also found that Rac, rather
than Rho, plays the major role in regulating stiffness-induced
N-cadherin expression. As we recently demonstrated that Rac
is a target of FAK and p130Cas in mesenchymal cells (Bae
et al., 2014), it is fitting that Rac regulates N-cadherin expression.
ECM stiffness and cell spreading are reported to stimulate
YAP and TAZ translocation into the nucleus, where they regulate
gene transcription (Dupont et al., 2011; Tang et al., 2013). Cad-
herins and catenins are also important molecular players that
regulate the localization of YAP/TAZ to modulate their transcrip-
tional activity (Kim et al., 2011; Robinson and Moberg, 2011; Sil-
vis et al., 2011). It is interesting to posit that crosstalk between
cadherin and integrin signaling may culminate in the transcrip-
tion of cell-cycle-regulatory genes by YAP/TAZ. We are currently
investigating the role of YAP as well as other mechanorespon-
sive transcriptional regulators, such MRTF-A and NFkB (Janmey
et al., 2013), in N-cadherin stimulated cell cycling.
While cadherins have been widely reported to arrest cell
growth by regulating contact inhibition (Kim et al., 2011;
McClatchey and Yap, 2012), pro-proliferative effects have also
been observed (Fournier et al., 2008; Nelson et al., 2004; Reddy
et al., 2005; Zhu and Watt, 1996). Our data suggest that cadher-
ins are intrinsically neither pro- nor anti-proliferative. Rather, we
propose that the proliferative outcome of cadherin engagement
is modulated by contextual cues from the microenvironment.
Our studies show that one of these contextual cues is the degree
of cell spreading. Cell spreading is affected by the ECM compo-
sition and the differential expression or engagement of specific(F and H) Injured femoral arteries from vehicle- and tamoxifen-treated N-cadherinfl
lies between the dashed white lines, which mark the internal and external elastic la
lumen.
(G) Quantification of results from (F); vehicle n = 4, tamoxifen n = 5.
(I) Quantification of results from (H); vehicle n = 5, tamoxifen n = 5. Results in (G)
See also Figure S5.
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cell-type specific, and likely contribute to the different prolifera-
tive effects of cadherin-mediated cell-cell adhesion.
EXPERIMENTAL PROCEDURES
In Vivo Vascular Injury
Femoral arteries of wild-type mice and mice in which N-cadherin or FAK
had been selectively deleted from SMCs were injured. The number of bromo-
deoxyuridine (BrdU)- or EdU-positive nuclei per peak section was determined
by using a method similar to that described by Kothapalli et al. (2007). Mouse
procedures and protocols were approved by the University of Pennsylvania
Institutional Animal Care and Use Committee.
Cell Proliferation on Micropatterned Adhesive Islands
Micropatterned adhesive islands were prepared as previously described
(Nelson et al., 2007) and coated with a 50 mg/ml FN solution. Serum-starved
SMCs (2 3 104) were seeded on micropatterns in DMEM/F12 containing
10% FBS with EdU for 48 hr. Cells were then fixed in 3.7% formaldehyde in
PBS and analyzed for EdU incorporation using the Click-iT EdU Imaging kit (In-
vitrogen) according to the manufacturer’s instructions. Only single or paired
cells were analyzed in the unpaired and paired micropatterns, respectively.
The percentage of EdU-incorporated cells was determined relative to DAPI-
stained nuclei. At least 100 cells were counted per condition.
Analysis of Confocal Microscopy Images
Confocal images from fluorescently stained SMCs cultured on unpaired and
paired micropatterned adhesive islands of different areas (2,500 mm2 and
10,000 mm2) were acquired using a Leica TCS SP8 laser scanning confocal
with a 203, 0.75 NA air immersion objective. FAKpY397 and N-cadherin fluores-
cence signal intensities for each unpaired cell or pair of cells were summed
from three consecutive sections using FIJI software. The total signal intensity
for FAKpY397 was then normalized to the spread area of each cell or pair of
cells. Total N-cadherin signal intensity was measured from traced regions of
cell-cell contact for paired cells (n = 5–9).
SUPPLEMENTAL INFORMATION
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and five figures and can be found with this article online at http://dx.doi.org/
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